ArticlePCN reports : psychiatry and clinical neurosciences2026
A case of marked improvement in pareidolia in untreated schizophrenia following antipsychotic treatment.
Article in PCN reports : psychiatry and clinical neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pareidolia, the tendency to perceive meaningful images within ambiguous visual patterns, is commonly observed in neurodegenerative disorders and schizophrenia. Owing to the limited number of studies, the characteristics of pareidolia accompanying schizophrenia remain unclear. Case Presentation: We present the case of an 85-year-old woman with untreated schizophrenia for nearly 60 years, in whom pareidolia was observed. On evaluation using the Noise Pareidolia Test, the patient initially scored 16/40 correct responses, 24/40 pareidolic responses, and 0/8 misses. After antipsychotic treatment with 15 mg of olanzapine or 24 mg of aripiprazole, pareidolia completely disappeared. However, during the treatment course, pareidolia recurred when the antipsychotic dose was reduced owing to a medication switch. Conclusion: Even in schizophrenia with an insufficient response to pharmacotherapy, pareidolia may still demonstrate treatment responsiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.